IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.647
AS - Asia 8.494
EU - Europa 4.751
SA - Sud America 1.570
AF - Africa 202
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.356
SG - Singapore 3.949
CN - Cina 1.686
BR - Brasile 1.244
UA - Ucraina 1.062
HK - Hong Kong 860
IT - Italia 818
VN - Vietnam 771
DE - Germania 675
FI - Finlandia 414
RU - Federazione Russa 362
FR - Francia 356
GB - Regno Unito 253
BD - Bangladesh 243
IE - Irlanda 242
SE - Svezia 223
IN - India 203
TR - Turchia 189
CA - Canada 158
AR - Argentina 120
KR - Corea 112
JP - Giappone 68
AT - Austria 66
IQ - Iraq 66
EC - Ecuador 64
ZA - Sudafrica 64
ID - Indonesia 58
MX - Messico 58
NL - Olanda 56
PL - Polonia 44
CO - Colombia 42
PK - Pakistan 35
ES - Italia 34
CZ - Repubblica Ceca 29
EG - Egitto 29
UZ - Uzbekistan 29
IR - Iran 28
BE - Belgio 25
MA - Marocco 25
CL - Cile 24
SA - Arabia Saudita 24
PY - Paraguay 23
VE - Venezuela 22
PH - Filippine 21
TG - Togo 20
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
LT - Lituania 16
MY - Malesia 13
AZ - Azerbaigian 12
CR - Costa Rica 12
UY - Uruguay 12
JO - Giordania 11
KZ - Kazakistan 11
OM - Oman 11
DO - Repubblica Dominicana 10
GR - Grecia 10
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 10
TT - Trinidad e Tobago 10
BO - Bolivia 9
DZ - Algeria 9
IL - Israele 9
AL - Albania 7
LB - Libano 7
RO - Romania 7
TH - Thailandia 7
TW - Taiwan 7
EE - Estonia 6
EU - Europa 6
KG - Kirghizistan 6
LK - Sri Lanka 6
BY - Bielorussia 5
HR - Croazia 5
NZ - Nuova Zelanda 5
AU - Australia 4
BB - Barbados 4
BS - Bahamas 4
CH - Svizzera 4
ET - Etiopia 4
HN - Honduras 4
NO - Norvegia 4
PA - Panama 4
BN - Brunei Darussalam 3
GA - Gabon 3
KW - Kuwait 3
PS - Palestinian Territory 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
GT - Guatemala 2
Totale 30.636
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.584
Ashburn 1.173
Ann Arbor 1.122
Fairfield 1.061
Houston 982
Beijing 845
Hong Kong 833
Chandler 767
Jacksonville 682
San Jose 574
Wilmington 520
Council Bluffs 467
Seattle 445
Dearborn 415
Boardman 413
Cambridge 335
Lauterbourg 285
Los Angeles 247
Dublin 239
Ho Chi Minh City 239
Princeton 229
Udine 180
Dallas 172
Izmir 138
Hanoi 136
Buffalo 129
Hefei 129
São Paulo 125
Santa Clara 111
Helsinki 107
Seoul 105
New York 102
Redondo Beach 97
Des Moines 86
Dong Ket 80
San Diego 80
Munich 79
Milan 71
Nuremberg 70
The Dalles 70
Ogden 60
Orem 57
Frankfurt am Main 55
Norwalk 50
Ottawa 44
Tokyo 44
London 43
Redmond 41
Warsaw 40
Nanjing 38
Atlanta 37
Brooklyn 37
Johannesburg 37
Rio de Janeiro 37
Montreal 36
Rome 36
Mumbai 35
Trieste 35
Toronto 33
Phoenix 32
Amsterdam 30
Chennai 29
Denver 29
Pittsburgh 29
Belo Horizonte 28
Stockholm 28
Tashkent 28
Da Nang 27
Haiphong 27
Belluno 26
Chicago 26
San Mateo 26
Lappeenranta 25
Düsseldorf 24
Guangzhou 24
Curitiba 23
Vienna 23
Brasília 22
Guayaquil 22
Quito 22
Brno 21
Baghdad 20
Brussels 20
Hải Dương 20
Lomé 20
San Francisco 20
Salvador 19
Turku 19
Manchester 18
Mexico City 18
Shanghai 18
Boston 17
Porto Alegre 17
Biên Hòa 16
Kunming 16
Poplar 16
Auburn Hills 15
Falls Church 15
Goiânia 15
Totale 18.842
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 201
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 200
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 192
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 188
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 188
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 186
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 185
Validation of the classification criteria for cryoglobulinaemic vasculitis. 183
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 183
Pain management in cryoglobulinaemic syndrome 183
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 182
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 178
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 175
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 174
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 171
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 170
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 169
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 167
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 165
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 165
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 164
Use of teriparatide in osteoporosis due to active rheumatic diseases 163
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 163
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 162
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 162
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 161
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 160
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 159
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 159
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 157
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 157
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 156
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 156
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 152
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 152
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 151
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 151
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 151
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 151
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 150
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 150
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 150
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 149
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 149
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 148
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 148
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 147
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 146
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 145
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 145
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 144
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 143
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 142
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 142
Classification of cryoglobulinemic vasculitis 140
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 140
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 140
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 139
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 139
Myositis in primary sjögren's syndrome: data from a multicenter cohort 138
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 137
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 137
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 136
Gastrointestinal Involvement in Systemic Vasculitis 136
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 135
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 135
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 134
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 133
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 133
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 132
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 131
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 131
Rituximab for rheumatoid arthritis refractory to both conventional therapy and anti-tumor necrosis factor therapy: results of a multi-centre observational italian studyann 130
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 129
Post-covid-19 arthritis and sacroiliitis: Natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature 129
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 128
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 128
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 127
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 127
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 126
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 126
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 125
Gastrointestinal involvement in systemic vasculitis 125
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 124
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 124
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 124
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 124
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 123
efficacy of methotrexate in polymyalgia rheumatica 123
Preliminary classification criteria for the cryoglobulinaemic vasculitis 123
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 122
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 122
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 121
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 121
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 121
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 120
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 120
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 119
Chlamydophila psittaci subclinical infection in chronic polyarthritis 119
Totale 14.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/202610.730 789 1.026 943 1.044 1.543 919 1.092 391 735 872 837 539
2026/2027374 374 0 0 0 0 0 0 0 0 0 0 0
Totale 31.674